Device and method for the combined electropharmacological treatment of the bladder and the prostatic urethra

Claim 2

Device for the combined electropharmacological treatment of the bladder, urethra and prostate comprising a bougie that comprises a flexible tubular body having a distal tip which is provided, at a proximal end, with a connector having at least one inlet, said body having, at a distal end, openings for connection to an outside, an opening in its tip and elastic sealing means for obstructing a prostatic urethra arranged perimetrically around it, said bougie being internally provided with an electrode that comprises at least two independent conductors that slide axially, each conductor having an insulated portion and conducting portions that are mutually spaced.

Claim 3

Device according to claim 1, wherein the conducting portion of at least a first one of said conductors is located at the distal end of said bougie and the conducting portion of at least a second one of said conductors is located at a level of the proximal end of the bougie.

Claim 4

Device according to claim 2, wherein the conducting portion of said second conductor is spiral-shaped and is coiled around the insulated portion of said first conductor.

Claim 5

Device according to claim 2, wherein the conducting portion of said first conductor has, at a distal end, a multidirectional ground electrode that can be extracted through the opening in the tip of the tubular body.

Claim 6

Device according to claim 4, wherein said multidirectional ground electrode comprises a spherical center that is rigidly coupled to the end of said first conductor, multiple elastically flexible conducting spokes extending radially from said center.

Claim 7

Device according to claim 1, wherein said independent conductors can be powered independently of one another.

Claim 8

Device according to claim 1, wherein said independent conductors are two.

Claim 9

Device according to claim 7, wherein one of the two conductors is shorter than the other one.

Claim 10

Device according to claim 8, wherein the conducting portion of said shorter conductor is spiral-shaped and is coiled around the insulated portion of the second conductor.

Claim 11

Device according to claim 8, wherein the longer conductor has, at a distal end, a multidirectional ground electrode that can be extracted through the opening in the tip of the tubular body.

Claim 12

Device according to claim 10, wherein said multidirectional ground electrode comprises a spherical center that is rigidly coupled to the end of said longer conductor, multiple elastically flexible conducting spokes extending radially from said center.

Claim 13

Device according to claim 1, wherein said elastic sealing means are constituted by a bag that can be dilated during use and that in its active configuration is suitable to obstruct the prostatic urethra upstream of the bladder.

Claim 14

Method for the simultaneous electropharmacological treatment of the bladder, urethra and prostate, comprising the steps of: placing a bougie along a prostatic urethra so that a distal end enters a bladder, inserting an electrode, which is divided into at least two independent conductors of different lengths so as to allow an end of a longer conductor to pass through an opening of a tip of the bougie to allow a multidirectional ground electrode to open out radially inside the bladder and, simultaneously, arranging a second conductor along the prostatic urethra, applying a second external counter-electrode in an external body region at the organs to be treated, electrically connecting said electrode inserted into the bougie to an external circuit that includes an electric current source connected to the external counter-electrode, infusing a solution through an inlet of the connector that comprises at least one drug suitable to treat affections involving the bladder and the prostate and, simultaneously, applying a potential difference between said, electrode and said second external counter-electrode, thereby producing an electric field suitable to cause the migration of said at least one drug into the tissues of the bladder and of the prostate.

Claim 15

Method for the simultaneous electropharmacological treatment of the bladder, urethra and prostate, comprising the steps of: placing a bougie along a prostatic urethra so that a distal end enters a bladder, inserting an electrode, which is divided into at least two independent conductors of different lengths so as to allow an end of a longer conductor to pass through an opening of a tip of the bougie to allow a multidirectional ground electrode to open out radially inside the bladder and, simultaneously, arranging a second conductor along the prostatic urethra, applying a second external counter-electrode in an external body region at the organs to be treated, electrically connecting said electrode inserted into the bougie to an external circuit that includes an electric current source connected to the external counter-electrode, infusing a solution through an inlet of the connector that comprises at least one drug suitable to treat affections involving the bladder and the prostate and, simultaneously, applying a potential difference between said, electrode and said second external counter-electrode, thereby producing an electric field suitable to cause the migration of said at least one drug into the tissues of the bladder and of the prostate.

Claim 16

Treatment method according to claim 13, further comprising the step of supplying a current to said conductors at different potential values to allow differentiated migration of the dissolved ions.

Claim 17

Treatment method according to claim 14, further comprising the step of supplying a higher voltage to the electrode located at a more severely affected organ, therefore allowing a larger amount of drug to be administered to tissues that most need to be treated.

Claim 18

Treatment method according to claim 13, further comprising the step of supplying a large amount of solution of the drugs in order to dilate the bladder tissue and fill the bladder cavity so that it acts as a solution containment vessel, said solution subsequently flowing out through the prostatic urethra, allowing an additional therapeutic treatment of the urethral tissue.